Yasser Ged, MBBS

I am a medical oncologist dedicated to the care of patients with genitourinary malignancies, with a clinical and research focus on renal cell carcinoma (RCC) and testicular cancer. My work centers on advancing novel therapeutic strategies and improving outcomes for patients with kidney cancer through clinical trials, translational research, and multidisciplinary care.
I completed Higher Specialist Training in Medical Oncology through the Royal College of Physicians of Ireland, followed by an Advanced Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center in New York, with a focus on genitourinary malignancies. At Johns Hopkins, I care for patients with kidney and testicular cancers and lead clinical and translational research efforts aimed at improving treatment strategies and patient outcomes.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Aptitude HealthTopic:honorariaDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MJH Life SciencesTopic:honorariaDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Matrix Medical CommunicationsTopic:honorariaDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:AveoDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:AbbvieDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:BostonGeneDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:EisaiDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:ExelixisDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Kura OncologyDate added:10/08/2026Date updated:10/08/2026
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:MerckDate added:10/08/2026Date updated:10/08/2026

Facebook
X
LinkedIn
Forward